Stockhead’s Investor Presentation gives executives of emerging ASX-listed companies the opportunity to present their latest investor presentation to current and potential investors.

This week, Stockhead heard from Mark Leong, executive chairman of Osteopore (ASX:OSX)

Osteopore specialises in the production of 3D-printed bioresorbable implants that are used in conjunction with surgical procedures to assist with the natural stages of bone healing.

The company recently made headlines signing an agreement with Kontour allowing for the first step towards gaining entry into the Chinese market.